Paul Greengard, Ph.D.
Paul Greengard, Ph.D.
Scientific Council Member (Joined 1986)
2008, 2002, 1992 Distinguished Investigator Grant
1996 Lieber Prize for Outstanding Achievement in Schizophrenia Research
Dr. Greengard's interests have ranged from basic neural explorations to therapeutic agents’ development for neurological and psychiatric disease treatments. The goal of his research is to understand the molecular basis of communication between neurons in the mammalian brain, elucidate the molecular defects responsible for various neurological and psychiatric disorders and determine the molecular mechanisms by which neuro- and psychoactive drugs produce their pharmacological actions. His groundbreaking work on signal transduction in the nervous system was recognized in 2000 with the Nobel Prize in Physiology or Medicine (shared with Arvid Carsson and Eric Kandel). Dr. Greengard is collaborating in a study to identify all expressed genes in individual cell types that have been implicated in schizophrenia and other neuropsychiatric disorders.
Dr. Greengard received his Ph.D. in biophysics from The Johns Hopkins University. Prior to joining the Rockefeller University, he was director of biochemical research at the Geigy Research Laboratories and a professor of pharmacology and psychiatry at Yale University. Since 1995, he has directed the Fisher Center for Alzheimer’s disease Research at Rockefeller.
Learn More About the Foundation
The Brain & Behavior Research Foundation is a global nonprofit organization focused on improving the understanding, prevention and treatment of psychiatric and mental illnesses.
Beginning in 1987, the Brain & Behavior Research Foundation was providing seed money to neuroscientists to invest in “out of the box” research that the government and other sources were unwilling to fund. Today, Brain & Behavior Research Foundation is still the leading, private philanthropy in the world in this space.
Meet the people who make up the Brain & Behavior Research Foundation. Our staff of experts, passionate Board of Directors, and Scientific Council which includes Nobel prize winners and chairs of psychiatric departments around the world.
We take our responsibility to our donors seriously and believe that our financial operations must be transparent. We're proud to say that 100% of your contribution for research is invested directly in research grants.